Versant Ventures VII GP, L.P., 10% Owner at LENZ Therapeutics, Inc. (LENZ), sold 375,130 shares at $38.97 ($14.8M) on 2025-08-26, disclosed to the SEC on 2025-08-26.
Open-market sale of $14.8M LENZ by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $40.03 | 20,493 | $820K | 5.5% |
| 2 | $40.03 | 10,076 | $403K | 2.7% |
| 3 | $40.03 | 10,076 | $403K | 2.7% |
| 4 | $40.03 | 20,493 | $820K | 5.5% |
| 5 | $40.59 | 2,809 | $114K | 0.8% |
| 6 | $40.59 | 2,809 |
| $114K |
| 0.8% |
| 7 | $40.59 | 5,668 | $230K | 1.6% |
| 8 | $40.59 | 5,668 | $230K | 1.6% |
| 9 | $39.53 | 24,760 | $979K | 6.6% |
| 10 | $39.53 | 24,760 | $979K | 6.6% |
| 11 | $39.53 | 50,270 | $2.0M | 13.4% |
| 12 | $39.53 | 50,270 | $2.0M | 13.4% |
| 13 | $39.92 | 1,058 | $42K | 0.3% |
| 14 | $39.92 | 2,149 | $86K | 0.6% |
| 15 | $39.92 | 2,149 | $86K | 0.6% |
| 16 | $38.97 | 21,661 | $844K | 5.7% |
| 17 | $38.97 | 43,978 | $1.7M | 11.6% |
| 18 | $38.97 | 43,978 | $1.7M | 11.6% |
| 19 | $38.97 | 21,661 | $844K | 5.7% |
| 20 | $39.50 | 1,707 | $67K | 0.5% |
| 21 | $39.50 | 3,465 | $137K | 0.9% |
| 22 | $39.50 | 1,707 | $67K | 0.5% |
| 23 | $39.50 | 3,465 | $137K | 0.9% |
| Total | $39.47 avg | 375,130 | $14.8M | 100% |